Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
Gain Therapeutics Inc GANX
$1.88
β² +5.62%
(+$0.10)
Open
$1.81
Prev Close
$1.78
Day Range
$1.80 β $1.90
52W Range
$1.41 β $4.34
Market Cap
$80.19M
Beta
0.16
EPS (TTM)
$-0.60
π Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-03-18 |
| Shares Out. | 42,650,000 |
| Website | gaintherapeutics.com/ β |
| Phone | 13015001556 |
Gain Therapeutics Inc is a publicly traded company under the ticker symbol GANX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
11 analysts (2026-06-01)
